An artificially constructed radiation-responsive promoter is activated by doxorubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An artificially constructed radiation-responsive promoter is activated by doxorubicin

Published:2012-03-09 Issue:5 Volume:19 Page:345-351
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Ogawa R,Morii A,Watanabe A,Cui Z-G,Kagiya G,Doi N,Zhao Q L,Feril L B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt20127.pdf

Reference23 articles.

1. Oliver SE, May MT, Gunnell D . International trends in prostate-cancer mortality in the ‘PSA era’. Int J Cancer 2001; 92: 893–898.

2. Immediate versus deferred treatment for advanced prostate cancer: initial result of the Medical Research Council Trial. Br J Urol 1997; 79: 235–246.

3. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502–1512.

4. Petrylak DP, Tangen CM, Hussain MHA, Lara Jr PN, Jones JA, Taplin ME et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 2004; 351: 1513–1520.

5. Kikuno N, Urakami S, Nakamura S, Hiraoka T, Hyuga T, Arichi N et al. Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer. Eur Urol 2007; 51: 1252–1258.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-Polymer Nanoparticles for Folate-Receptor Targeting Delivery of Doxorubicin;Journal of Nanoscience and Nanotechnology;2015-07-01

2. Development of a therapeutically important radiation induced promoter;Bioengineered;2013-01

3. Regulation of gene expression in human prostate cancer cells with artificially constructed promoters that are activated in response to ultrasound stimulation;Ultrasonics Sonochemistry;2013-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3